Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 37.20B | 37.54B | 41.78B | 43.84B | 54.50B | 40.02B |
Gross Profit | 13.17B | 13.60B | 17.70B | 19.81B | 32.77B | 20.98B |
EBITDA | 13.49B | 12.94B | 15.56B | 23.74B | 32.23B | 19.95B |
Net Income | 5.82B | 6.10B | 7.98B | 18.79B | 22.45B | 4.88B |
Balance Sheet | ||||||
Total Assets | 83.43B | 80.25B | 94.19B | 86.89B | 89.44B | 92.01B |
Cash, Cash Equivalents and Short-Term Investments | 4.00B | 5.01B | 3.66B | 4.80B | 11.90B | 14.26B |
Total Debt | 18.55B | 17.74B | 16.80B | 15.44B | 17.20B | 20.11B |
Total Liabilities | 47.07B | 45.69B | 53.20B | 49.54B | 54.14B | 57.19B |
Stockholders Equity | 35.21B | 33.43B | 39.46B | 35.87B | 34.47B | 35.74B |
Cash Flow | ||||||
Free Cash Flow | 1.15B | 2.92B | 7.25B | 6.04B | 20.65B | 10.10B |
Operating Cash Flow | 7.46B | 9.37B | 13.16B | 11.48B | 25.68B | 14.32B |
Investing Cash Flow | -5.22B | -5.37B | -6.32B | -4.69B | -6.61B | -4.67B |
Financing Cash Flow | -1.78B | -2.27B | -7.34B | -13.91B | -20.28B | -2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $98.68B | 8.44 | 21.04% | 7.66% | -0.28% | 15.20% | |
76 Outperform | $126.48B | 11.50 | 26.13% | 3.97% | -3.15% | 54.08% | |
70 Neutral | $41.69B | 7.33 | 15.98% | 15.11% | -9.59% | -25.35% | |
69 Neutral | $1.75B | 179.78 | 1.14% | 0.66% | 6.97% | -87.87% | |
56 Neutral | $651.60M | ― | -16.64% | 2.06% | 12.30% | 42.72% | |
54 Neutral | $5.10B | ― | -9.62% | ― | 4.63% | -3189.81% | |
44 Neutral | C$969.59M | -6.68 | -13.73% | 2.50% | 17.55% | -32.57% |